Principal Researcher
Prof. Jamal Mahajna
Plant-Based Cancer Drugs
972-50-4242634
Our main interest in the cancer drug discovery program revolves around cancer drug resistance, and in particular, in Ph+ leukemia.
Latest Publications
Ovarian cancer ascites confers platinum chemoresistance to ovarian cancer cells.
Translational Oncol. 10.1016/j.tranon.2024.101939
2024
Chaga Mushroom Triterpenoids Inhibit Dihydrofolate Reductase and Act Synergistically with Conventional Therapies in Breast Cancer
Biomolecules, 14(11), 1454
2024
Ovarian cancer ascites confers platinum chemoresistance to ovarian cancer cells
2024
Secreted soluble factors from tumor-activated mesenchymal stromal cells confer platinum chemoresistance to OC cells and JAK and c-MET kinase inhibitors restore platinum sensitivity to ovarian cancer cells
Int. J. Mol. Sci. 2023, 24(9), 7730;
2023